Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
1.
Environ Int ; 162: 107153, 2022 04.
Article in English | MEDLINE | ID: covidwho-1706132

ABSTRACT

Since December 2019, coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a great challenge to the world's public health system. Nosocomial infections have occurred frequently in medical institutions worldwide during this pandemic. Thus, there is an urgent need to construct an effective surveillance and early warning system for pathogen exposure and infection to prevent nosocomial infections in negative-pressure wards. In this study, visualization and construction of an infection risk assessment of SARS-CoV-2 through aerosol and surface transmission in a negative-pressure ward were performed to describe the distribution regularity and infection risk of SARS-CoV-2, the critical factors of infection, the air changes per hour (ACHs) and the viral variation that affect infection risk. The SARS-CoV-2 distribution data from this model were verified by field test data from the Wuhan Huoshenshan Hospital ICU ward. ACHs have a great impact on the infection risk from airborne exposure, while they have little effect on the infection risk from surface exposure. The variant strains demonstrated significantly increased viral loads and risks of infection. The level of protection for nurses and surgeons should be increased when treating patients infected with variant strains, and new disinfection methods, electrostatic adsorption and other air purification methods should be used in all human environments. The results of this study may provide a theoretical reference and technical support for reducing the occurrence of nosocomial infections.


Subject(s)
COVID-19 , SARS-CoV-2 , Aerosols , Humans , Patient Isolators , Risk Assessment
2.
J Korean Acad Nurs ; 51(5): 585-596, 2021 Oct.
Article in Korean | MEDLINE | ID: covidwho-1504472

ABSTRACT

PURPOSE: The purpose of this study was to explore nurses' experience with caring for COVID-19 patients in a negative pressure room amid the spread of the pandemic. METHODS: This study was a qualitative research, and focus group interviews were used to collect data. Three focus groups comprising 19 nurses were interviewed from February 17 to 25, 2021. All interviews were recorded and transcribed verbatim with the consent of the participants. The verbatim transcripts were scrutinized using thematic analysis. RESULTS: Two main themes emerged from the analysis: 'Struggling in an isolated space' and 'Limitations of nursing infrastructure and system'. The nurses caring for COVID-19 patients experienced anxiety and fear about the infection, physical exhaustion, emotional burnout, and a sense of duty as a nurse. They also acknowledged the lack of guidelines, increased task and burden, limitations of nursing care, and the demand for improving the limitations of the nursing system. CONCLUSION: The results of this study demonstrate that nurses caring for COVID-19 patients encounter physical and emotional problems within the limited healthcare system. The study suggests that comprehensive interventions are needed for nurses. Furthermore, detailed guidelines, strengthening of nursing personnel, and improvements to the nursing system are vital to effectively cope with the pandemic. The government and medical institutions should be aware of the needs of nurses and what they are going through, and make efforts to improve the quality of life of healthcare workers and create a safe healthcare environment.


Subject(s)
COVID-19 , Nurses , Humans , Pandemics , Patient Isolators , Qualitative Research , Quality of Life , SARS-CoV-2
3.
PLoS One ; 16(5): e0251153, 2021.
Article in English | MEDLINE | ID: covidwho-1225810

ABSTRACT

As COVID-19 spreads across the United States, people experiencing homelessness (PEH) are among the most vulnerable to the virus. To mitigate transmission, municipal governments are procuring isolation facilities for PEH to utilize following possible exposure to the virus. Here we describe the framework for anticipating isolation bed demand in PEH communities that we developed to support public health planning in Austin, Texas during March 2020. Using a mathematical model of COVID-19 transmission, we projected that, under no social distancing orders, a maximum of 299 (95% Confidence Interval: 223, 321) PEH may require isolation rooms in the same week. Based on these analyses, Austin Public Health finalized a lease agreement for 205 isolation rooms on March 27th 2020. As of October 7th 2020, a maximum of 130 rooms have been used on a single day, and a total of 602 PEH have used the facility. As a general rule of thumb, we expect the peak proportion of the PEH population that will require isolation to be roughly triple the projected peak daily incidence in the city. This framework can guide the provisioning of COVID-19 isolation and post-acute care facilities for high risk communities throughout the United States.


Subject(s)
COVID-19/transmission , Forecasting/methods , Patient Isolators/supply & distribution , COVID-19/epidemiology , Ill-Housed Persons/statistics & numerical data , Humans , Models, Theoretical , Patient Isolation/instrumentation , Patient Isolation/trends , Public Health , SARS-CoV-2/pathogenicity , United States
4.
Sci Prog ; 104(2): 368504211009670, 2021.
Article in English | MEDLINE | ID: covidwho-1195898

ABSTRACT

As the coronavirus disease 2019 (COVID-19) spreads globally, hospital departments will need take steps to manage their treatment procedures and wards. The preparations of high-risk departments (infection, respiratory, emergency, and intensive care unit) were relatively well within this pandemic, while low-risk departments may be unprepared. The spine surgery department in The First Affiliated Hospital of Anhui Medical University in Hefei, China, was used as an example in this study. The spine surgery department took measures to manage the patients, medical staff and wards to avoid the cross-infection within hospital. During the outbreak, no patients or healthcare workers were infected, and no treatment was delayed due to these measures. The prevention and control measures effectively reduced the risk of nosocomial transmission between health workers and patients while providing optimum care. It was a feasible management approach that was applicable to most low-risk and even high-risk departments.


Subject(s)
COVID-19/prevention & control , Infection Control/methods , Pandemics , Patient Isolation/organization & administration , Patient Isolators/supply & distribution , SARS-CoV-2/pathogenicity , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/transmission , China/epidemiology , Cross Infection/prevention & control , Disinfection/methods , Disinfection/organization & administration , Health Personnel/education , Humans , Infection Control/organization & administration , Monitoring, Physiologic/instrumentation , Monitoring, Physiologic/methods , Orthopedic Procedures/instrumentation , Orthopedic Procedures/methods , Patient Isolation/methods , Patients' Rooms/organization & administration , Personal Protective Equipment/supply & distribution , Spine/surgery
5.
J Healthc Eng ; 2021: 8872167, 2021.
Article in English | MEDLINE | ID: covidwho-1175220

ABSTRACT

In the beginning of 2020, the coronavirus (COVID-19) pandemic started to spread globally, causing panic to the lives of people around the world; many countries executed lockdown of cities or even total lockdown of the entire countries. The coronavirus disease (COVID-19) is transmitted via air droplets. In medical environments that use traditional hermetic ventilation systems, medical personnel who come in contact with patients are more susceptible to infection compared to regular staff; therefore, the air flow and air quality of hermetic negative pressure isolation wards are highly critical. For this purpose, the study proposes a full-outer-air-intake natural air-conditioning system for negative pressure isolation wards. This innovative system draws in large amounts of fresh external air to greatly improve the air exchange rate in wards; negative pressure environments can be implemented depending on requirements to solve the issue of nosocomial infections in traditional negative pressure isolation wards that draw air from within the hospital. This greatly reduces the probability of nosocomial infection and infection via air droplets; furthermore, the system's intake and exhaust paths are completely isolated, solving the issue of air cross-contamination. Based on the results from the experiment site, this innovative system was designed and implemented based on the guidelines of hospital facilities and achieved air exchange per hour in excess of 12 times/hour, reaching a maximum of 54.5 times/hour. Indoor CO2 concentration was 576 ppm, negative pressure was -14 Pa, indoor temperature was 23.3°C, indoor humidity was 54.1%, and sensible heat exchange efficiency (ηs) was 105.88% which effectively reduced ventilation load. Therefore, this innovative full-outer-air-intake natural air-conditioning system can provide medical staff and patients with a safe and healthy environment that prevents cross-infection.


Subject(s)
Air Conditioning , Air Pollutants , COVID-19/prevention & control , Infection Control/instrumentation , Patient Isolation/instrumentation , Patient Isolators , Air Pollution, Indoor/analysis , Carbon Dioxide/analysis , Equipment Design , Guidelines as Topic , Hospitals , Hot Temperature , Humans , Humidity , Occupational Exposure/prevention & control , SARS-CoV-2 , Ventilation
6.
Ann R Coll Surg Engl ; 103(5): e144-e147, 2021 May.
Article in English | MEDLINE | ID: covidwho-1120812

ABSTRACT

The current global COVID-19 pandemic is caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, acquired tracheoesophageal fistulas are mainly iatrogenic lesions produced by prolonged tracheal intubation. We present a case of tracheoesophageal fistula with severe tracheal stenosis following tracheal intubation in a patient with SARS-CoV-2 infection.


Subject(s)
COVID-19/therapy , Intubation, Intratracheal/adverse effects , Otorhinolaryngologic Surgical Procedures/methods , Respiratory Distress Syndrome/therapy , Tracheal Stenosis/surgery , Tracheoesophageal Fistula/surgery , Adult , Anastomosis, Surgical/methods , Bronchoscopy/methods , COVID-19/complications , Humans , Male , Operating Rooms , Patient Isolators , Respiration, Artificial , Respiratory Distress Syndrome/etiology , SARS-CoV-2 , Tomography, X-Ray Computed , Tracheal Stenosis/etiology , Tracheoesophageal Fistula/etiology
7.
Ann R Coll Surg Engl ; 103(3): 151-154, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-1110067

ABSTRACT

INTRODUCTION: Owing to the COVID-19 pandemic, there has been significant disruption to all surgical specialties. In the UK, units have cancelled elective surgery and a decrease in aerosol generating procedures (AGPs) was favoured. Centres around the world advocate the use of negative pressure environments for AGPs in reducing the spread of infectious airborne particles. We present an overview of operating theatre ventilation systems and the respective evidence with relation to surgical site infection (SSI) and airborne pathogen transmission in light of COVID-19. METHODS: A literature search was conducted using the PubMed, Cochrane Library and MEDLINE databases. Search terms included "COVID-19", "theatre ventilation", "laminar", "turbulent" and "negative pressure". FINDINGS: Evidence for laminar flow ventilation in reducing the rate of SSI in orthopaedic surgery is widely documented. There is little evidence to support its use in general surgery. Following previous viral outbreaks, some centres have introduced negative pressure ventilation in an attempt to decrease exposure of airborne pathogens to staff and surrounding areas. This has again been suggested during the COVID-19 pandemic. A limited number of studies show some positive results for the use of negative pressure ventilation systems and reduction in spread of pathogens; however, cost, accessibility and duration of conversion remain an unexplored issue. Overall, there is insufficient evidence to advocate large scale conversion at this time. Nevertheless, it may be useful for each centre to have its own negative pressure room available for AGPs and high risk patients.


Subject(s)
Air Filters , COVID-19/prevention & control , Environment, Controlled , Operating Rooms , Patient Isolators , Surgical Procedures, Operative/methods , Ventilation/methods , COVID-19/transmission , Humans , Orthopedic Procedures , SARS-CoV-2 , Surgical Wound Infection/prevention & control
8.
J Med Microbiol ; 70(3)2021 Mar.
Article in English | MEDLINE | ID: covidwho-1101944

ABSTRACT

This study tests the release of SARS-CoV-2 RNA into the air during normal breathing, without any sign of possible risk of contagion such as coughing, sneezing or talking. Five patients underwent oropharyngeal, nasopharyngeal and salivary swabs for real-time reverse transcriptase PCR (RT-PCR) detection of SARS-CoV-2 RNA. Direct SARS-CoV-2 release during normal breathing was also investigated by RT-PCR in air samples collected using a microbiological sampler. Viral RNA was detected in air at 1 cm from the mouth of patients whose oropharyngeal, nasopharyngeal and salivary swabs tested positive for SARS-CoV-2 RNA. In contrast, the viral RNA was not identified in the exhaled air from patients with oropharyngeal, nasopharyngeal and salivary swabs that tested negative. Contagion of SARS-CoV-2 is possible by being very close to the mouth of someone who is infected, asymptomatic and simply breathing.


Subject(s)
Air Microbiology , COVID-19/virology , SARS-CoV-2/isolation & purification , Aerosols/analysis , Aged , COVID-19/diagnosis , COVID-19 Nucleic Acid Testing , Cross Infection/diagnosis , Cross Infection/virology , Hospitals , Humans , Italy/epidemiology , Nasopharynx/virology , Oropharynx/virology , Patient Isolators , SARS-CoV-2/genetics , Saliva/virology
9.
Clin Transl Gastroenterol ; 12(2): e00314, 2021 02 18.
Article in English | MEDLINE | ID: covidwho-1097482

ABSTRACT

INTRODUCTION: During the coronavirus disease 2019 (COVID-19) pandemic, endoscopists have high risks of exposure to exhaled air from patients during gastroscopy. To minimize this risk, we transformed the oxygen mask into a fully closed negative-pressure gastroscope isolation mask. This study aimed to evaluate the effectiveness, safety, and feasibility of use of this mask during gastroscopy. METHODS: From February 28, 2020, to March 10, 2020, 320 patients undergoing gastroscopy were randomly assigned into the mask group (n = 160) or conventional group (n = 160). Patients in the mask group wore the isolation mask during gastroscopy, whereas patients in the conventional group did not wear the mask. The adenosine triphosphate fluorescence and carbon dioxide (CO2) concentration in patients' exhaled air were measured to reflect the degree of environmental pollution by exhaled air. Patients' vital signs, operation time, and adverse events during endoscopy were also evaluated. RESULTS: Four patients were excluded because of noncooperation or incomplete data. A total of 316 patients were included in the final analysis. The difference between the highest CO2 concentration around patients' mouth and CO2 concentration in the environment was significantly decreased in the mask group compared with the conventional group. There was no significant difference in the adenosine triphosphate fluorescence, vital signs, and operation time between the 2 groups. No severe adverse events related to the isolation mask, endoscopy failure, or new coronavirus infection during follow-up were recorded. DISCUSSION: This new isolation mask showed excellent feasibility of use and safety compared with routine gastroscopy during the COVID-19 pandemic.


Subject(s)
COVID-19/transmission , Gastroscopy/adverse effects , Masks/virology , Patient Isolators/virology , Adenosine Triphosphate/metabolism , Adult , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/virology , Carbon Dioxide/analysis , Case-Control Studies , Equipment Design/methods , Exhalation/physiology , Feasibility Studies , Female , Fluorescence , Gastroscopy/methods , Humans , Male , Masks/adverse effects , Masks/statistics & numerical data , Middle Aged , Operative Time , Prospective Studies , SARS-CoV-2/genetics , Safety , Treatment Outcome
10.
A A Pract ; 14(14): e01360, 2020 Dec 17.
Article in English | MEDLINE | ID: covidwho-1067373

ABSTRACT

This single-center retrospective study evaluated a protocol for the intubation of patients with confirmed or suspected coronavirus disease 2019 (COVID-19). Twenty-one patients were intubated, 9 of whom were found to have COVID-19. Adherence to the airway management protocol was high. COVID-19 patients had lower peripheral capillary oxygen saturation by pulse oximetry (Spo2) nadirs during intubation (Spo2, 73% [72%-77%] vs 89% [86%-94%], P = .024), and a greater percentage experienced severe hypoxemia defined as Spo2 ≤80% (89% vs 25%, P = .008). The incidence of severe hypoxemia in COVID-19 patients should be considered in the development of guidelines that incorporate high-flow nasal cannula and noninvasive positive pressure ventilation.


Subject(s)
COVID-19/therapy , Hypoxia/therapy , Intubation, Intratracheal/methods , Rapid Sequence Induction and Intubation/methods , Respiratory Insufficiency/therapy , Adult , Aged , Airway Management , Cannula , Female , Humans , Hypoxia/prevention & control , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Laryngoscopy , Male , Middle Aged , N95 Respirators , Noninvasive Ventilation , Oximetry , Oxygen Inhalation Therapy , Patient Isolators , Personal Protective Equipment , Positive-Pressure Respiration , Practice Guidelines as Topic , Retrospective Studies , SARS-CoV-2 , Severity of Illness Index
11.
Respiration ; 100(1): 27-33, 2021.
Article in English | MEDLINE | ID: covidwho-1064198

ABSTRACT

BACKGROUND: Bronchoscopic sampling of bronchoalveolar fluid (BAL) should be safe and effective. Current sampling practice risks loss of sample to the attached negative flow, aerosolisation, or spillage, due to repeated circuit breaks, when replacing sample containers. Such concerns were highlighted during the recent coronavirus pandemic. OBJECTIVES: Evaluation of an alternative integrated sampling solution, with the Ambu Bronchosampler with aScope 4, by an experienced bronchoscopist in ICU. METHODS: An observational study of 20 sequential bronchoscopic diagnostic sampling procedures was performed on mechanically ventilated patients with suspected ventilator-associated pneumonia. Mixed methods assessment was done. The predefined outcome measures were (1) ease of set up, (2) ease of specimen collection, (3) ease of protecting specimen from loss or spillage, and (4) overall workflow. The duration of the procedure and the % volume of sample retrieved were recorded. RESULTS: The mean (±standard deviation [SD]) time for collecting 1 sample was 2.5 ± 0.8 min. The mean (±SD) specimen yield for instilled miniBAL was 54.2 ± 17.9%. Compared with standard sampling, the set-up was much easier in 18 (90%), or easier in 2 (10%) of procedures, reducing the connection steps. It was much more intuitive to use in 14 (70%), more intuitive in 4 (20%), and no more intuitive to use in 2 (10%). The overall set-up and workflow was much easier in 69% of the 13 intraprocedural connections and easier or as easy in the remaining 31% procedures. All procedures where pre connection was established were much easier (7, 100%). The Ambu Bronchosampler remained upright in all procedures with no loss or spillage of sample. Obtaining a sample was much easier in 60%, easier in 10%, no different in 20%, and worse in 10%. The ability to protect a sample from start to finish compared to standard procedures was much easier in 80%, easier in 15%, and no different in 5% of procedures. Overall workflow was much easier in 14 (70%), easier in 4 (20%), and no different in 2 (10%) of procedures. CONCLUSIONS: The Ambu Bronchosampler unit was a reliable, effective, and possibly safer technique for diagnostic sampling in ICU. It may improve safety standards during the coronavirus pandemic. A randomized control trial against the standard sampling technique is warranted.


Subject(s)
Bronchoscopes , Bronchoscopy/methods , Disposable Equipment , Respiration, Artificial , Specimen Handling/methods , Bronchoalveolar Lavage/instrumentation , Bronchoalveolar Lavage/methods , Bronchoalveolar Lavage Fluid , Bronchoscopy/instrumentation , COVID-19/prevention & control , COVID-19/transmission , Humans , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Occupational Exposure/prevention & control , Patient Isolators , Personal Protective Equipment , Pneumonia, Ventilator-Associated/diagnosis , Risk Assessment , SARS-CoV-2
13.
Otolaryngol Head Neck Surg ; 163(6): 1134-1136, 2020 12.
Article in English | MEDLINE | ID: covidwho-1042348

ABSTRACT

The outbreak of novel coronavirus disease 2019 (COVID-19) has had a momentous impact on the field of otolaryngology due to the high number of aerosol-generating procedures involving the upper aerodigestive tract. These procedures bear significant risk to the provider and clinical environment due to the possibility of viral aerosolization. While significant attention has been appropriately paid to personal protective equipment during this pandemic, an understanding of industrial hygiene is also necessary for the safe delivery of health care to mitigate the risk of exposure to other patients and health care workers. We provide a review of air ventilation practices and their role in reducing pathogen spread. In addition, we share our experiences with effectively treating COVID-19-positive patients aboard the USNS Comfort through proper environment control measures.


Subject(s)
COVID-19/prevention & control , Disease Transmission, Infectious/prevention & control , Infection Control/methods , Pandemics , Patient Isolators , COVID-19/transmission , Health Personnel , Humans , New York City , Otolaryngology , Personal Protective Equipment , SARS-CoV-2 , Ships , Ventilation
15.
Semin Perinatol ; 44(7): 151282, 2020 11.
Article in English | MEDLINE | ID: covidwho-1029108

ABSTRACT

As we confront COVID-19, the global public health emergency of our times, new knowledge is emerging that, combined with information from prior epidemics, can provide insights on how to manage this threat in specific patient populations. Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), both caused by coronaviruses, caused serious respiratory illness in pregnant women that resulted in adverse perinatal outcomes. Thus far, COVID-19 appears to follow a mild course in the vast majority of pregnant women. A significant proportion of pregnant women appear to be asymptomatic carriers of SARS-CoV-2. However, there is limited information on how COVID-19 impacts the fetus and whether vertical transmission occurs. While these knowledge gaps are addressed, it is important to recognize the highly efficient transmission characteristics of SARS-C0V-2 and its potential for causing serious disease in vulnerable individuals, including health care workers. This review provides perspectives from a single center in New York City, the epicenter of the pandemic within the United States. It offers an overview of the preparations required for deliveries of newborns of mothers with COVID-19 and the management of neonates with particular emphasis on those born with complex issues.


Subject(s)
COVID-19 , Congenital Abnormalities/therapy , Intensive Care, Neonatal/methods , Pregnancy Complications, Infectious , Advanced Practice Nursing , COVID-19 Testing , Esophageal Atresia/therapy , Extracorporeal Membrane Oxygenation , Female , Heart Defects, Congenital/therapy , Hernias, Diaphragmatic, Congenital/therapy , Humans , Infant, Newborn , Infection Control , Infectious Disease Transmission, Vertical , Intensive Care, Neonatal/organization & administration , Neonatologists , Nurses, Neonatal , Patient Care Planning , Patient Care Team/organization & administration , Patient Isolation , Patient Isolators , Pregnancy , Plastic Surgery Procedures , Resuscitation/methods , SARS-CoV-2 , Time Factors , Tracheoesophageal Fistula/therapy
16.
Semin Perinatol ; 44(7): 151280, 2020 11.
Article in English | MEDLINE | ID: covidwho-1027921

ABSTRACT

OBJECTIVE: To describe inpatient management strategies and considerations for pregnant patients with severe acute respiratory syndrome coronavirus 2 infection. FINDINGS: The novel coronavirus has posed challenges to both obstetric patients and the staff caring for them, due to its variable presentation and current limited knowledge about the disease. Inpatient antepartum, intrapartum and postpartum management can be informed by risk stratification, severity of disease, and gestational age. Careful planning and anticipation of emergent situations can prevent unnecessary exposures to patients and clinical staff. CONCLUSION: As new data arises, management recommendations will evolve, thus practitioners must maintain a low threshold for adaptation of their clinical practice during obstetric care for patients with severe acute respiratory syndrome coronavirus 2 infection.


Subject(s)
COVID-19/therapy , Delivery, Obstetric , Fetal Monitoring , Hospitalization , Pregnancy Complications, Infectious/therapy , Adrenal Cortex Hormones/therapeutic use , Anti-Bacterial Agents/therapeutic use , Anticoagulants/therapeutic use , Antiviral Agents/therapeutic use , COVID-19/diagnosis , COVID-19 Nucleic Acid Testing , Cesarean Section , Chorioamnionitis/diagnosis , Delivery Rooms , Diagnosis, Differential , Disease Management , Endometritis/diagnosis , Female , Fetal Organ Maturity , Gestational Age , HELLP Syndrome/diagnosis , Humans , Immunization, Passive , Influenza, Human/diagnosis , Intensive Care Units , Labor, Induced , Obstetric Labor, Premature/drug therapy , Patient Discharge , Patient Isolators , Personal Protective Equipment , Postnatal Care , Practice Guidelines as Topic , Pre-Eclampsia/diagnosis , Pregnancy , Pyelonephritis/diagnosis , Rooming-in Care , SARS-CoV-2 , Severity of Illness Index , Thrombosis/prevention & control , Time Factors , Tocolytic Agents/therapeutic use , COVID-19 Drug Treatment , COVID-19 Serotherapy
17.
Auris Nasus Larynx ; 48(3): 525-529, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1014322

ABSTRACT

OBJECTIVE: Involvement in the tracheostomy procedure for COVID-19 patients can lead to a feeling of fear in medical staff. To address concerns over infection, we gathered and analyzed experiences with tracheostomy in the COVID-19 patient population from all over Japan. METHODS: The data for health-care workers involved in tracheostomies for COVID-19-infected patients were gathered from academic medical centers or their affiliated hospitals from all over Japan. RESULTS: Tracheostomies have been performed in 35 COVID-19 patients with a total of 91 surgeons, 49 anesthesiologists, and 49 surgical staff members involved. Twenty-eight (80%) patients underwent surgery more than 22 days after the development of COVID-19-related symptoms (11: 22-28 days and 17: ≥29 days). Thirty (85.7%) patients underwent surgery ≥ 15 days after intubation (14: 15-21 days, 6: 22-28 days, and 10: ≥29 days). Among the total of 189 health-care workers involved in the tracheostomy procedures, 25 used a powered air-purifying respirator (PAPR) and 164 used a N95 mask and eye protection. As a result, no transmission to staff occurred during the 2 weeks of follow-up after surgery. CONCLUSION: No one involved in tracheostomy procedures were found to have been infected with COVID-19 in this Japanese study. The reason is thought to be that the timing of the surgery was quite late after the infections, and the surgery was performed using appropriate PPE and surgical procedure. The indications for and timing of tracheostomy for severe COVID-19 patients should be decided through multidisciplinary discussion.


Subject(s)
COVID-19/therapy , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Respiratory Insufficiency/therapy , Tracheostomy/methods , Extracorporeal Membrane Oxygenation , Eye Protective Devices , Health Personnel , Humans , Infectious Disease Transmission, Patient-to-Professional/statistics & numerical data , Japan , N95 Respirators , Patient Isolators , Personal Protective Equipment , Respiration, Artificial/methods , Respiratory Protective Devices , SARS-CoV-2
19.
Eur Rev Med Pharmacol Sci ; 24(23): 12558-12574, 2020 12.
Article in English | MEDLINE | ID: covidwho-995016

ABSTRACT

The Coronavirus Disease 2019 (COVID-19) is a viral infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which emerged in East Asia and spread around the world from December 2019. The most severe stage of COVID-19 pathology is characterized by respiratory distress requiring intubation. In specific cases, tracheostomy is indicated to ensure the safety of the procedure. The aim of our study was to analyze the scientific literature identifying the indications for tracheostomy and safety precautions to reduce contamination. We analyzed the literature from February 2003 to April 2020, including papers on pandemics of other coronaviruses, such As Severe Acute Respiratory Syndrome Coronavirus 1 and Middle East Respiratory Syndrome Coronavirus, to obtain a variety of relevant information. We focused on indications for tracheostomy in patients affected by COVID-19 or related viruses and the measures adopted to perform a safe procedure. We included 35 papers, of which 24 (68.57%) discussed guidelines for tracheostomy indications. All 35 studies discussed the procedures for performing tracheostomy safely. Data obtained indicated that the authors generally agreed on safety measures but expressed different opinions about indications. Therefore, we provided guidelines addressing safety recommendations. After the pandemic has been resolved, we plan to conduct an international retrospective study to identify the criteria for tracheostomy indications.


Subject(s)
COVID-19/therapy , Respiratory Insufficiency/therapy , Tracheostomy/methods , Airway Management/methods , COVID-19/prevention & control , COVID-19/transmission , Coronavirus Infections , Eye Protective Devices , Humans , Infectious Disease Transmission, Patient-to-Professional/prevention & control , N95 Respirators , Patient Isolators , Personal Protective Equipment , Respiration, Artificial/methods , Respiratory Protective Devices , SARS-CoV-2 , Severe Acute Respiratory Syndrome , Time Factors
20.
J Perioper Pract ; 31(1-2): 44-50, 2021.
Article in English | MEDLINE | ID: covidwho-965746

ABSTRACT

One of the priorities at our large Operating Theatres Department is to support awareness and basic education of the multi-disciplinary teams in clinical Human Factors, to help build competence and capacity in healthcare towards a resilient system. From May 2019 until February 2020, our Human Factors Champions embarked on a project called Observation of Non-technical Skills and Teamwork in the operating theatres (ONSeT), to monitor and evaluate the benefits of local Human Factors education. In September 2020, six months after the COVID-19 pandemic hit the UK and caused a major disruption of surgical services, we decided to investigate the usefulness of the project and the impact of COVID-19 in the operating theatres, looking through the eyes of the Human Factors Champions. Results pointed to a consensus about ONSeT having helped during the pandemic, with regards to how teams worked and in enabling team leaders to be more responsive. Human Factors Champions found that feedback on performance was received in a non-threatening way and observation of performance became 'second nature'. As organisations need to develop critical thinking, we think that the ONSeT project has helped us build some capacity for this, from the front-line onwards.


Subject(s)
Coronavirus Infections/prevention & control , Health Personnel/standards , Infection Control/methods , Infection Control/standards , Operating Rooms/standards , Patient Isolators/standards , Perioperative Care/standards , Adult , COVID-19 , Female , Humans , Male , Middle Aged , Pandemics , Practice Guidelines as Topic , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL